XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.2
OTHER (INCOME) EXPENSE, NET
 6 Months Ended
Jun. 30, 2025
Other Income and Expenses [Abstract]  
OTHER (INCOME) EXPENSE, NET OTHER (INCOME) EXPENSE, NET
Other (income) expense, net consists of:
Three Months Ended June 30,Six Months Ended June 30,
(in millions)2025202420252024
Acquired in-process research and development costs$1 $3 $29 $3 
Acquisition-related transaction costs2 1 3 1 
Litigation and other matters, net of insurance recoveries and restitutions8 21 5 27 
Acquisition-related contingent consideration(29)(4)(40)(6)
Gain on sale of assets, net— (1)— (5)
$(18)$20 $(3)$20 
Acquired in-process research and development costs for the three and six months ended June 30, 2025 are primarily related to Bausch + Lomb’s acquisition of Whitecap Biosciences.
Acquisition-related contingent consideration for the three and six months ended June 30, 2025 and 2024 reflects adjustments for changes in estimates in the timing and amounts of expected future royalty and milestone payments and accretion for the time value of money.
For the six months ended June 30, 2025, Litigation and other matters, net of insurance recoveries and restitutions includes restitution received in connection with a certain legal matter. For the three and six months ended June 30, 2024, Litigation and other matters, net of insurance recoveries and restitutions primarily relates to provisions for certain legal matters.